In bladder cancer, USP21 is highly expressed and patients with high expression levels have poor survival, and USP21 can accelerate the proliferation and metastasis of bladder cancer cells via inhibiting EZH2 ubiquitination (Chen et al., 2017). The gene discussed is EZH2; the disease is urinary bladder carcinoma.